Form 4: Phreesia Director Exercises Options and Sells Shares Under Pre-Arranged Plan

Sentiment:

Insider Transaction Report


Phreesia, Inc. Director Mark Douglas Smith exercised stock options and subsequently sold an equivalent number of common shares on July 2, 2025, as part of a pre-arranged trading plan.

Summary

  • Director Mark Douglas Smith of Phreesia, Inc. engaged in transactions involving the company's common stock.
  • On July 2, 2025, Smith exercised stock options to acquire 7,000 shares of common stock at an exercise price of $4.71 per share.
  • Immediately following the option exercise, Smith sold 7,000 shares of common stock at a price of $29.00 per share.
  • These transactions were conducted under a Rule 10b5-1 trading plan established on January 10, 2025.
  • Following these transactions, Smith directly beneficially owns 37,353 shares of common stock and 51,193 stock options.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction where a director exercised options and sold shares for a profit, executed under a pre-arranged trading plan, which is generally viewed neutrally or slightly positively due to transparency.

Positives

  • Director Mark Douglas Smith realized a significant profit by selling shares at $29.00 after exercising options at $4.71.
  • The transactions were executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled and transparent sale not based on inside information.

Negatives

  • Director Mark Douglas Smith sold 7,000 shares of common stock, which could be interpreted by some investors as a reduction in direct ownership stake, although it was part of an option exercise and sale.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • Director Mark Douglas Smith exercised stock options and sold common stock of Phreesia, Inc., which constitutes an insider transaction.

Stakeholder Impact

  • Shareholders may view the sale as a director reducing exposure, but the execution under a Rule 10b5-1 plan mitigates negative interpretations.
  • The profit realized by the director from the option exercise and sale could be seen as a positive sign of value creation for long-term shareholders.

Key Dates

DateDescription
01/10/2025Rule 10b5-1 trading plan adopted by the Reporting Person.
07/02/2025Date of earliest transaction, including stock option exercise and common stock sale.
07/03/2025Signature date of the Form 4 filing.
09/04/2028Expiration date of the exercised stock option.

Keywords

Phreesia, PHR, Form 4, Insider Transaction, Stock Options, Director, Share Sale, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.